Skip to main content
Log in

Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues

  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

Properly formulated probiotic-containing foods offer consumers a low risk, low cost dietary component that has the potential to promote health in a variety of ways. Several such products are available commercially, although markets in Japan and Europe are more developed than in the USA. Once healthful attributes of a probiotic product have been identified, there remain microbiological, product, regulatory and labeling issues to be addressed prior to marketing. Microbiological and product issues include safety, effective scale-up for manufacturing, definition of probiotic activity, probiotic stability in the product over the course of product manufacture, shelf-life and consumption, definition of effective dose and target population(s), and development of quality assurance approaches. Examples of probiotic-containing foods are given. Regulatory and labeling issues are complicated because they differ for each country, but are likewise critical because they provide the means for c ommunication of the product benefits to the consumer. The regulatory climate worldwide appears to be one of caution about overstating the benefits of such products but at the same time not preventing corporate commitment to marketing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams MR & Marteau P (1995) On the safety of lactic acid bacteria from food. Int. J. Food Microbiol. 27: 263-264

    Google Scholar 

  • Aguirre M & Collins MD (1993) Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75: 95-107

    Google Scholar 

  • Anon. (1996) Is yogurt the health food it's cracked up to be? Tufts Univ. Diet Nutr. Let. November, pp. 3-5

  • Anon. (1998) FDA denies numerous structure/function claims. Food Regulation Weekly, Nov. 23, 1998

  • Arthur M & Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. A minireview. Antimicrob. Agents Chemother. 37: 1563-1571

    Google Scholar 

  • Arthur M, Reynolds P & Courvalin P (1996) Glycopeptide resistance in enterococci. Trends in Microbiol. 4: 401-407

    Google Scholar 

  • Aso Y & Akazan H (1992) Prophylactic effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP study group. Urol. Int. 49: 125-129

    Google Scholar 

  • Berner LA & O'Donnell JA (1998) Functional foods and health claims legislations: applications to dairy foods. Int. Dairy J. 8: 355-362

    Google Scholar 

  • Canganella F, Paganini S, Ovidi M, Vettraino AM, Bevilacqua L, Massa S & Trovatelli LD (1997) A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol. Res. 152: 171-179

    Google Scholar 

  • Collins JK, Thornton G & Sullivan GO (1998) Selection of probiotic strains for human applications. Int. Dairy J. 8: 487-490

    Google Scholar 

  • Donohue DC, Deighton M, Ahokas JT & Salminen S (1993) Toxicity of lactic acid bacteria. In: Salminen and von Wright (Eds.) Lactic Acid Bacteria, (pp 307-313). Marcel Dekker, Inc., New York

    Google Scholar 

  • Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrisey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EMM, O'Sullivan GC, Shanahan F & Collins JK (1999) Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. These proceedings.

  • Fonden R, Mogensen G, Tanaka R & Salminen S (1999) Effect of fermented dairy products on intestinal microflora, human nutrition and health: current knowledge and future perspectives. IDF Document. (In press)

  • Gasser F (1994) Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur 92: 45-67

    Google Scholar 

  • Giraffa G, Carminati D & Neviani E (1997) Enterococci isolated from dairy products: a review of risks and potential technological use. J. Food Protect. 60: 732-738

    Google Scholar 

  • Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L & Salminen S (1992) Survival of Lactobacillus species (Strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37: 121-128

    Google Scholar 

  • Guarner F & Schaafsma GJ (1998) Probiotics. Int. J. Food Microbiol. 39: 237-238

    Google Scholar 

  • Hamilton-Miller JMT, Shah S & Smith CT (1996) 'Probiotic' remedies are not what they seem. Brit. Med. J. 312: 55-56

    Google Scholar 

  • Hamilton-Miller JMT, Shah S & Winkler JT (1999) Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr. (in press)

  • Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y & Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Amer. J. Clin. Nutr. 64: 767-771

    Google Scholar 

  • Havenaar R & Huis in't Veld JHJ (1992) Probiotics: a general view. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 151-170). Elsevier Applied Science, London

    Google Scholar 

  • Holzapfel WH, Haberer P, Snel J, Schillinger U & Huis in't Veld JHJ (1998) Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85-101

    Google Scholar 

  • Hosono A, Lee J, Ametani A, Natsume M, Hirayama M, Adachi T & Kaminogawa S (1997). Characterization of a water-soluble poly-saccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci. Biotech. Biochem. 61: 312-316

    Google Scholar 

  • Huis in't Veld JHJ & Havenaar R (1997) Selection criteria and application of probiotic microorganisms in man and animal. Microecol. Ther. 26: 43-57

    Google Scholar 

  • Jett BD, Huycke MM & Gilmore MS (1994) Virulence of enterococci. Clin Microbiol. Rev. 7: 462-478

    Google Scholar 

  • Kampman E, Goldbohm RA, van den Brandt PA & van't Veer P (1994) Fermented dairy products, calcium and colorectal cancer in the Netherlands cohort study. Cancer Res. 54: 3186-3190

    Google Scholar 

  • Kurtzweil P (1998) Staking a claim to good health. FDA and science stand behind health claims on foods. FDA Consumer, Nov-Dec. http://vm.cfsan.fda.gov/~dms/

  • Langseth L (1996) Nutritional epidemiology: possibilities and limitations. ILSI Press, Washington, DC

    Google Scholar 

  • Maeno M, Yamamoto N & Takano T (1996) Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 73: 1316-1321

    Google Scholar 

  • Marin ML, Lee JH, Murtha J, Ustunol Z & Pestka JJ (1997) Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 80: 2713-2720

    Google Scholar 

  • Marteau P, Minekus M, Havenaar R & Huis in't Veld JHJ (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effect of bile. J. Dairy Sci. 80: 1031-1037

    Google Scholar 

  • McNamara SH (1998) So you want to market a food and to make health-related claims — How far can you go? What rules of law will govern the claims you want to make? Food Drug Law J. 53: 421-436

    Google Scholar 

  • Micanel N, Haynes IN & Playne MJ (1997) Viability of probiotic cultures in commercial Australian yogurts. Aust. J. Dairy Technol. 52: 24-27

    Google Scholar 

  • Millar MR, Bacon C, Smith SL, Walker V & Hall MA (1993) Enteral feeding of premature infants with Lactobacillus GG. Arch. Dis. Childhood 69: 483-487

    Google Scholar 

  • Minekus M, Smeets-Peeters M, Bernalier A, Marol S, Havenaar R, Marteau P, Alric M, Fonty G & Huis in't Veld JHJ (1999) A computer-controlled model of the large intestine with peristaltic mixing, absorption of fermentation products and a high-density microflora. (in press)

  • Minekus M, Marteau P, Havenaar R & Huis in't Veld JHJ (1995) A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA (Alternative To Laboratory Animals) 23: 197-209

    Google Scholar 

  • Molin G, Jeppsson B, Johansson M-L, Ahrne S, Nobaek S, Stahl M & Bengmark S (1993) Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Bacteriol. 74: 314-323

    Google Scholar 

  • Monique GLe, Moulton LH, Hill C & Kramar A (1986) Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Nat. Cancer Instil. 77: 633-636.

    Google Scholar 

  • Noble WC, Virani Z & Cree RGA (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93: 195-198

    Google Scholar 

  • Perdigon G, Nader de Macias ME, Alvarez S, Oliver G & Pesce de Ruiz Holgado AA (1986) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53: 404-410

    Google Scholar 

  • Peters RK, Pike MC, Garabrant D & Mack TM (1992) Diet and colon cancer in Los Angeles County, California. Cancer Causes and Control 3: 457-473

    Google Scholar 

  • Reuter G (1997) Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora 16: 43-51

    Google Scholar 

  • Roberfroid MB (1998) Prebiotics and synbiotics: concepts and nutritional properties. Brit. J. Nutr. 80: S197-S202

    Google Scholar 

  • Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fonden R, Saxelin M, Collins K, Mogensen G, Birkeland S-E & Mattila-Sandholm T (1998). Demonstration of safety of probiotics — a review. Int. J. Food. Microbiol. 44: 93-106

    Google Scholar 

  • Salminen S, Isolauri E & Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains for future challenges. Antonie Van Leeuwenhoek 70: 347-358

    Google Scholar 

  • Sanders ME (1998) Development of consumer probiotics for the US market. Brit. J. Nutr. 80: S213-S218

    Google Scholar 

  • Sanders ME, Walker DC, Walker KM, Aoyama K & Klaenhammer TR (1996) Performance of commercial cultures in fluid milk applications. J. Dairy Sci. 79: 943-955

    Google Scholar 

  • Savaiano DA, AbouElAnouar A, Smith DE & Levitt MD (1984) Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidiohilus milk, and cultured milk in lactase-deficient individuals. Amer. J. Clin. Nutr. 40: 1219-1223

    Google Scholar 

  • Saxelin M, (1997) Lactobacillus GG — a human probiotic strain with thorough clinical documentation. Food Rev. Int. 13: 293-313

    Google Scholar 

  • Saxelin M, Rautelin H, Salminen S & Makela PH (1996a) Safety of commercial products with viable lactobacillus strains. Infect. Dis. Clin. Pract. 5: 331-335

    Google Scholar 

  • Saxelin M, Chuang MH, Chassy B, Rautelin H, Makela PH, Salminen S & Gorbach SL (1996b) Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin. Infect. Dis. 22: 564-566

    Google Scholar 

  • Solis Pereyra B & Lemonnier D (1993) Induction of human cytokines by bacteria used in dairy foods. Nutr. Res. 13: 1127-1140

    Google Scholar 

  • Spanhaak S, Havenaar R & Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Europ. J. Clin. Nutr. 52: 899-907

    Google Scholar 

  • Storlie J, O'Flaherty MJ & Hare K (1998) Food or Supplement? Choosing the appropriate regulatory path. Food Technol. 52: 62-69

    Google Scholar 

  • Tannock GW (1999) Probiotics: A critical review. Horizon Press, Wymondham (Norfolk), UK

    Google Scholar 

  • Tannock GW (1998) Studies of the intestinal microflora: a prerequisite for the development of probiotics. Int. Dairy J. 8: 527-533

    Google Scholar 

  • Titze A, Kuhn C, Lorenz A, de Vrese M & Barth C (1996) The influence of viable lactobacilli on lactose degradation in the gut of gnotobiotic animals. XIIth International Symposium on Gnotobiology, Honolulu, pp. 43

  • Tomera JF (1996) Yogurt: probiotic pharmacology. Drugs of Today 32: 539-551

    Google Scholar 

  • Tomioka H & Saito H (1992) Lactic acid bacteria in the support of immuno-compromised hosts. In: Wood BJB (Ed.) The lactic acid bacteria: Vol. I The lactic acid bacteria in health and disease. (pp 263-296) Elsevier Applied Science, London

    Google Scholar 

  • van't Veer P, Dekker JM, Lamers JWJ, Kok FJ, Schouten EG, Brants HAM, Sturmans F & Hermus RJJ (1989) Cancer Res. 49: 4020-4023

    Google Scholar 

  • Vesa TH, Marteau Ph, Zidi S, Briet F, Pochart Ph & Rambaud JC (1996) Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters — Is bacterial lactase important? Euro. J. Clin. Nutr. 50: 730-733

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary Ellen Sanders.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanders, M.E., Huis in't Veld, J. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues. Antonie Van Leeuwenhoek 76, 293–315 (1999). https://doi.org/10.1023/A:1002029204834

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1002029204834

Keywords

Navigation